|1.||Leufkens, H G: 6 articles (01/2004 - 06/2001)|
|2.||Buurma, H: 6 articles (01/2004 - 06/2001)|
|3.||Tijssen, C C: 6 articles (01/2004 - 06/2001)|
|4.||Rahimtoola, H: 6 articles (01/2004 - 06/2001)|
|5.||Goadsby, P J: 4 articles (07/2006 - 01/2000)|
|6.||Boes, C J: 3 articles (10/2009 - 05/2002)|
|7.||Lipton, R B: 3 articles (08/2009 - 09/2000)|
|8.||Schoenen, J: 3 articles (04/2006 - 01/2000)|
|9.||Egberts, A C: 3 articles (01/2004 - 06/2001)|
|10.||Egberts, A C G: 3 articles (11/2003 - 05/2002)|
|1.||Migraine Disorders (Migraine)
09/01/1994 - "The original migraine therapy, ergotamine, is highly effective in its rectal suppository formulation, when used at a subnauseating dosage. "
01/01/1999 - "Ergotamine tartrate is usually taken only for acute migraine, but may also be effective for prevention of menstrual migraine when used regularly once or twice per day during the time of risk. "
09/01/2013 - "Ergotamine has been used for the treatment of migraine for many years, and its use in adults is considered to be safe and effective. "
05/01/2003 - "This study aims to investigate usage patterns of specific migraine prophylactic medications in ergotamine and triptan patients commencing this treatment for the first time during 1 January 1992 until 31 December 1998. "
01/01/2003 - "In this study we tried to investigate the role of multicomponent drugs containing ergotamine in the treatment of migraine in the adult workers group. "
11/01/1978 - "The regional and hemispheric CBF was unaltered, even in 3 migraneurs in who ergotamine relieved the headache. "
02/01/1999 - "We designed a standardized neurophysiological retrospective (ergotamine abuse) and prospective (ergotamine withdrawal) study in a supraregional headache outpatient clinic. "
12/03/2013 - "From headache to heartache: ergotamine-induced aortic and mitral valvulopathy."
10/01/2009 - "In a 1936 Journal of the American Medical Association article, she described a patient with ergotamine overuse headache and recommended that daily doses of oral ergotamine should be avoided. "
08/01/2008 - "In 1938 Graham and Wolff demonstrated the parallel decrease of temporal pulsations and headache after ergotamine i.v. This inspired the vascular theory of Wolff: an initial cerebral vasoconstriction followed by an extracranial vasodilation. "
09/01/1984 - "The pain was relieved with vasoconstricting preparations (ergotamine) and provoked with vasodilating medications (nitroglycerine). "
01/01/2003 - "Pain intensity during the 4th visit did not differ significantly vs placebo probably because of long action time for ergotamine. "
06/01/2000 - "At the end of three days of treatment, a total improvement of the pain symptoms was recorded, which allowed for the withdrawal of the ergotamine derivatives. "
06/01/2000 - "We describe three patients (female, aged 65 and 39 years, and male, 46) affected by cervicogenic headache (CH) and CDH linked to the overuse of pain-killers (ergotamine derivatives) that were submitted to the infiltration of the greater occipital nerve (GON). "
06/01/1984 - "Side-effects attributable to ergotamine were wide ranging and included daily headache and pain in the limbs. "
|4.||Cluster Headache (Cluster Headaches)
05/01/2002 - "He was probably one of the first to describe the cluster phenomenon itself and the effectiveness of ergotamine in treating acute attacks of cluster headache. "
01/01/2002 - "Oral ergotamine tartrate may be sufficient for patients with night attacks and/or short, rather mild to moderately severe cluster headache periods. "
03/01/1983 - "Only inhalation of ergotamine resulted in early (at 5 min) peak concentrations of ergotamine in plasma and is therefore most likely to relieve the short-lived attacks of cluster headache. "
03/01/1983 - "Bioavailability and rate of absorption of ergotamine were studied in eight cluster headache patients outside attacks. "
03/01/1983 - "Optimal routes of administration of ergotamine tartrate in cluster headache patients. "
07/01/1995 - "Among associated symptoms, nausea and vomiting were significantly less frequent (p = 0.024) in the analgesic group than in the group of patients with ergotamine intake."
07/01/1985 - "Principal adverse effects of ergotamine include nausea, vomiting, weakness, muscle pains, paraesthesiae and coldness of the extremities. "
03/01/1975 - "There was little evidence that doctors with 'classic' migraine differed from those with 'common' migraine in the proportion who experienced other migrainous features (unilateral distribution of headache and accompanying nausea) or in their response to treatment with ergotamine."
01/01/2003 - "The most common adverse events (incidence > or = 5% in one group) after rizatriptan and ergotamine/caffeine, respectively, were dizziness (6.7 and 5.3%), nausea (4.2 and 8.5%) and somnolence (5.5 and 2.3%)."
01/01/2004 - "The present study was specifically designed to compare the efficacy of the combination of lysine acetylsalicylate and metoclopramide (1620 mg LAS + 10 mg MTC--Migpriv) and ergotamine plus caffeine (2 mg ERG + 200 mg CAF--Coffecorn forte) in the treatment of migraine headache and nausea. "
|1.||Caffeine (No Doz)
|6.||Aspirin (Acetylsalicylic Acid)
|7.||ergotamine drug combination caffeine
|8.||Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
|9.||Analgesics (Analgesic Drugs)
|3.||Bed Rest (Bedrest)